Publications by authors named "Wei Jing Kelven Chen"

To compare the clinical outcomes and complication rates of convective water vapor energy ablation (Rezum) and prostatic urethral lift (Urolift). To identify predictive factors for treatment failures in both treatments. Prospective clinico-epidemiological data of patients who underwent Urolift or Rezum in a single institution for benign prostatic hyperplasia (BPH) was collected.

View Article and Find Full Text PDF

Purpose: To assess the effect of aromatherapy with lavender oil alone, and in combination with music, on pain and anxiety during extracorporeal shockwave lithotripsy for kidney stones.

Methods: This was a single-centre prospective, randomised controlled trial. The subjects were block randomised into 3 study groups, Group 1: Control; Group 2: Aromatherapy only; Group 3: Aromatherapy and music.

View Article and Find Full Text PDF

Objectives: To identify predictive factors for the development of sepsis/septic shock postdecompression of calculi-related ureteric obstruction using the Sequential Organ Failure Assessment (SOFA) score and to compare clinical outcomes and odd risk ratios of patients developing sepsis/septic shock following the insertion of percutaneous nephrostomy (PCN) versus insertion of retrograde ureteral stenting (RUS).

Methods: Clinico-epidemiological data of patients who underwent PCN and/or RUS in two institutions for calculi-related ureteric obstruction were retrospectively collected from January 2014 to December 2020.

Results: 537 patients (244 patients in PCN group, 293 patients in RUS group) from both institutions were eligible for analysis based on inclusion and exclusion criteria.

View Article and Find Full Text PDF
Article Synopsis
  • Transurethral needle ablation (TUNA) is a minimally invasive treatment for benign prostatic hyperplasia (BPH) that offers several benefits over traditional procedures like TURP, including avoidance of general anesthesia.* -
  • A study involving 121 patients analyzed outcomes after TUNA, showing significant improvements in symptoms, quality of life, and urinary flow rates, with notable results including a 65% improvement in IPSS and a 75% improvement in quality of life scores.* -
  • The findings suggest that TUNA is effective and safe for treating symptomatic BPH in selected patients, with a mean relapse-free survival of over 6 years and low complication rates reported.*
View Article and Find Full Text PDF